
HTG Molecular Diagnostics HTGM
Geschäftsbericht 2022
hinzugefügt 30.03.2023
HTG Molecular Diagnostics ROA 2011-2026 | HTGM
ROA Jährlich HTG Molecular Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -121.47 | -56.29 | -59.29 | -42.77 | -37.59 | -89.2 | -141.1 | -54.24 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -37.59 | -141.1 | -75.24 |
ROA Vierteljährlich HTG Molecular Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -82.53 | -95.54 | -75.37 | -55.86 | -33.26 | -48.63 | -50.99 | -60.21 | -47.11 | -57.61 | -52.74 | -47.15 | -33.04 | -44.11 | -44.67 | -43.41 | -32.73 | -58.04 | -72.29 | -90.4 | -80.16 | -115.31 | -125.16 | -134.81 | -110.36 | -123.45 | -101.39 | -80.64 | -39.85 | -77.74 | -102.54 | -128.38 | -112.51 | -112.51 | -74.61 | -32.4 | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -32.4 | -134.81 | -74.38 |
ROA anderer Aktien in der Diagnostik & Forschung
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | ||
|
Brainsway Ltd.
BWAY
|
-8.53 | - | - | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 29.8 | -3.87 % | $ 321 M | ||
|
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | ||
|
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
-37.07 | - | - | $ 79.8 M | ||
|
BioNano Genomics
BNGO
|
-146.1 | $ 1.13 | -3.54 % | $ 1.44 M | ||
|
Castle Biosciences
CSTL
|
3.43 | - | - | $ 914 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M | ||
|
Danaher Corporation
DHR
|
5.03 | $ 219.93 | 0.09 % | $ 161 B | ||
|
Celcuity
CELC
|
-45.6 | $ 104.25 | 0.08 % | $ 4.11 B | ||
|
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | ||
|
DexCom
DXCM
|
8.64 | - | - | $ 26.3 B | ||
|
Quest Diagnostics Incorporated
DGX
|
5.39 | $ 209.75 | 2.09 % | $ 23.3 B | ||
|
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | ||
|
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | ||
|
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
-40.76 | $ 19.51 | -5.18 % | $ 1.05 B | ||
|
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | ||
|
DarioHealth Corp.
DRIO
|
-61.65 | $ 11.07 | 1.37 % | $ 314 M | ||
|
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | ||
|
Exact Sciences Corporation
EXAS
|
-14.58 | $ 103.42 | - | $ 19.2 B | ||
|
Interpace Biosciences
IDXG
|
45.31 | $ 1.82 | - | $ 7.98 M | ||
|
Lantheus Holdings
LNTH
|
15.78 | $ 67.04 | - | $ 4.64 B | ||
|
Fulgent Genetics
FLGT
|
-3.5 | $ 23.02 | - | $ 696 M | ||
|
Mettler-Toledo International
MTD
|
23.41 | - | -0.62 % | $ 28.7 B | ||
|
Guardant Health
GH
|
-29.37 | $ 106.6 | 1.65 % | $ 13.1 B | ||
|
NeoGenomics
NEO
|
-4.81 | $ 11.47 | - | $ 1.45 B | ||
|
QIAGEN N.V.
QGEN
|
1.47 | - | - | $ 10.6 B | ||
|
Natera
NTRA
|
-39.28 | - | -0.5 % | $ 20.7 B | ||
|
OPKO Health
OPK
|
0.64 | $ 1.25 | 2.05 % | $ 868 M | ||
|
Charles River Laboratories International
CRL
|
0.29 | - | -9.16 % | $ 8.49 B | ||
|
Koninklijke Philips N.V.
PHG
|
10.73 | $ 32.03 | -2.72 % | $ 20 B | ||
|
IDEXX Laboratories
IDXX
|
26.96 | - | - | $ 53.5 B | ||
|
Illumina
ILMN
|
-19.4 | $ 117.01 | -1.95 % | $ 18.6 B | ||
|
IQVIA Holdings
IQV
|
5.1 | $ 176.27 | - | $ 32 B | ||
|
Biodesix
BDSX
|
-44.15 | - | - | $ 1.33 B | ||
|
Laboratory Corporation of America Holdings
LH
|
4.06 | $ 289.4 | 1.75 % | $ 24.3 B | ||
|
ENDRA Life Sciences
NDRA
|
-258.47 | $ 3.56 | -4.56 % | $ 1.91 M | ||
|
ICON Public Limited Company
ICLR
|
4.69 | - | - | $ 11 B | ||
|
Quidel Corporation
QDEL
|
43.3 | - | -3.13 % | $ 1.19 B | ||
|
Biomerica
BMRA
|
-83.65 | $ 2.23 | - | $ 5.12 M | ||
|
Bioventus
BVS
|
-19.27 | $ 8.04 | - | $ 504 M |